Westlake's Q2 Turnaround Was Real-But the Next 90 Days Decide If It Lasts

Westlake's Q2 swing was real, but durability is the harder question

Westlake's worst headline became its best selling point. After a Q1 operating loss of $172 million, the company reported $364 million of Q2 operating income, along with $2.01 per share and $3.3 billion in net sales. That kind of reversal pushes investors beyond the "one bad quarter" explanation and forces a sterner test: whether the turnaround has real traction.

What improved in Q2

Westlake said results benefited from a higher average sales price in our PEM segment, higher sales volume in our HIP segment, and its three-pillar profitability improvement plan. The bigger point is that this was not just a balance-sheet rescue. Operating income flipped from negative to positive, which makes the quarter harder to dismiss.

Why the next few quarters matter more than the headline

A stronger quarter also improved liquidity. Westlake reduced debt by $500 million, returned $99 million to shareholders via dividends and share repurchases, and finished Q2 with $1.9 billion in cash and investments. Still, this looks like progress rather than a clean bill of health. The company also ended the quarter with $5.1 billion in total debt, so the burden has lightened, not disappeared.

PEM led the improvement, while HIP showed a more mixed picture

The segment breakdown matters because both divisions contributed, but not with the same quality of recovery.

PEM had the stronger rebound

PEM delivered $416 million in EBITDA, up $364 million year-over-year. The segment also saw its average sales price rise 21% sequentially while sales volume increase 2% sequentially. That combination matters: demand was not moving only on price.

The pricing backdrop also had support from supply disruption. Management said the Middle East conflict disrupted 10% to 15% of global polyethylene, helping steer global demand toward Westlake's North American assets. At the same time, the company's gas-based feedstock position provided a significant competitive advantage as global oil and naphtha prices rose.

HIP improved, but margins still point to cost pressure

HIP was stable, not the star of the quarter. The segment generated $1.3 billion in net sales, organic sales volume growth: 6% year-over-year, and pipe and fittings sales volume grew roughly 20% year-over-year. But HIP EBITDA margin: 22%, down from 24% in the prior year period. That tells you pricing helped revenue, yet cost inflation still capped some of the margin benefit.

What to watch over the next earnings cycle

• PEM: Does volume stay positive if geopolitical support eases?
• HIP: Can margins recover toward last year's 24% as cost pass-through catches up?
• Parent company: Can Westlake turn one strong quarter into another quarter of operating and cash-flow improvement?

The balance sheet improved, but debt is still the real test

A cleaner balance sheet matters because turnaround profit only counts if it becomes cash. In Q2, Westlake reduced debt by $500 million and ended with $1.9 billion in cash and investments. That gives management more room to manage through a rougher backdrop.

But the leverage story is still central. Westlake ended Q2 with $5.1 billion in total debt, and the company still faces $900 million for 2026 in capital expenditures guidance and approximately $215 million in cash interest expense. One good quarter improves flexibility; sustained operating cash flow is what changes the trajectory.

WLKP adds a yield lens, but coverage is still the debate

The parent remains the main turnaround story. For Westlake Chemical Partners, the key issue is whether distribution coverage improves enough to support the yield case more comfortably.

WLKP coverage is improving, but it is still tight

WLKP's MLP distributable cash flow was $17.6 million, and net income attributable to the Partnership was $0.40 per limited partner unit, below the declared quarterly distribution of $0.4714 per unit. Operating cash flow improved sharply to $129.8 million, but MLP distributable cash flow slipped slightly from the first quarter, which keeps the coverage debate active.

What would strengthen the thesis

• WLKP improves its associated trailing twelve-month coverage ratio of 1.04x.
• Operating cash flow remains strong even after the prior year's turnaround benefits fade.
• Westlake keeps delivering on its three-pillar profitability improvement plan and its $600 million in total EBITDA uplift for 2026 target.

The question now is not whether Westlake can post one much better quarter. It is whether PEM pricing, HIP execution, and balance-sheet cleanup can hold up long enough for investors to treat this as a durable turnaround rather than a temporary relief move.